MACQUARIE GROUP LTD - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 83 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$28,000
-9.7%
2,183
-7.3%
0.00%
Q2 2022$31,000
-36.7%
2,3540.0%0.00%
Q1 2022$49,000
+2.1%
2,3540.0%0.00%
Q4 2021$48,000
-50.5%
2,354
-26.4%
0.00%
Q3 2021$97,000
+148.7%
3,197
+136.1%
0.00%
Q2 2021$39,000
-32.8%
1,3540.0%0.00%
Q1 2021$58,000
+100.0%
1,354
+115.6%
0.00%
Q4 2020$29,000
+7.4%
6280.0%0.00%
Q3 2020$27,000
-18.2%
6280.0%0.00%
Q2 2020$33,0006280.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders